MindImmune Therapeutics, Inc. is a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system, including Alzheimer’s and Huntington’s disease, pain, and psychiatric disorders.

Biotechnology

MindImmune Therapeutics

MindImmune Therapeutics' headquarters in South Kingstown, RI, United States

Stevin Zorn

Frank S. Menniti

Richard G. Horan

MindImmune Therapeutics' Leadership Team includes Robert B. Nelson and 3 others.

About

People (3)

Frank S. Menniti

Robert B. Nelson

Stevin Zorn

Jobs